Notification of Major Interest in Shares

RNS Number : 8801L
Faron Pharmaceuticals Oy
06 October 2016
 

 

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES



1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached:

 

Faron Pharmaceuticals Oy

2. Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights


 

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached.

 


 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

 


An event changing the breakdown of voting rights


 

Other (please specify):

 

Disclosure as per company's Articles of Association

Yes

3. Full name of person(s) subject to the
notification obligation:

 

Legal & General Investment Management Limited (LGIM)

 

Legal & General (Unit Trust Managers) Limited (UTM)

4. Full name of shareholder(s)
 (if different from 3.):

-

 

 

5. Date of the transaction and date on
which the threshold is crossed or
reached:

 

21 September 2016

6. Date on which issuer notified:

05 October 2016

7. Threshold(s) that is/are crossed or
reached:

 

 

LGIM (Above 3%, 4%)

 

UTM (Above 3%, 4%)

 



 

8. Notified details:

 

A: Voting rights attached to shares

Class/type of
shares


if possible using
the ISIN CODE

Situation previous
to the triggering
transaction

Resulting situation after the triggering transaction

Number
of
Shares

Number
of
Voting
Rights

 

Number
of shares

Number of voting
rights

% of  voting rights

Direct

Indirect

Direct

Indirect

ORD NPV

Nil

 1,080,000

 

1,080,000

 

4.10%


B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

 

Type of financial
instrument

 

Expiration
date

 

Exercise/
Conversion Period

Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.

 

% of voting
rights







C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

 

Type of financial
instrument

 

 

Exercise price

 

Expiration date

 

Exercise/
Conversion period

 

Number of voting rights instrument refers to

 

 

% of voting rights

 





 

 

Nominal

Delta



 

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

                                                                

1,080,000 (LGIM)

 

4.10%

 

1,080,000 (UTM)

 

4.10%



 

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:

 

Legal & General Group Plc (Direct and Indirect) (Group)  (1,080,000, 4.10% = Total Position)


Legal & General Investment Management (Holdings) Limited (LGIMH) (Direct and Indirect)  (1,080,000, 4.10% = Total Position)


Legal & General Investment Management Limited (Indirect) (LGIM) (1,080,000, 4.10% = Total Position)

 

Legal & General (Unit Trust Managers) Limited (1,080,000, 4.10% = UTM)



Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will cease
to hold:

N/A

12. Date on which proxy holder will cease to hold
voting rights:

N/A



13. Additional information:

Notification using the total voting rights figure of  26,311,704  

14. Contact name:

Victoria Davies (LGIM)

15. Contact telephone number:

029 2035 4147

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLGIBDGSSGBGLL
UK 100

Latest directors dealings